Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: The Impact of CYP2D6 Polymorphism on Tramadol Pharmacodynamics

View source ↗

Summary

A clinical trial update studying how CYP2D6 genetic variation influences tramadol pharmacodynamics in post-cesarean pain, with the study currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tramadol (tramadol)

Snippet

Sponsor: Elweyia Maternity Teaching Hospital | Conditions: Post-cesarean Pain, CYP2D6 Polymorphism | Status: ACTIVE_NOT_RECRUITING